SCHEMBL8791905

SCHEMBL8791905

Cn1c2c(c3ccccc31)C(NC1CC1)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17278963 0.76 GPR3 (0.45) —
SCHEMBL12153701 0.71 — —
SCHEMBL17286462 0.71 — —
SCHEMBL21088785 0.68 RB1 (0.51) —
SCHEMBL15891557 0.67 MCHR1 (0.52) —
SCHEMBL11686226 0.67 — —
SCHEMBL28991545 0.67 — —
SCHEMBL15891558 0.66 MCHR1 (0.52) —
SCHEMBL19168645 0.66 HDAC2 (0.50) —
SCHEMBL16559077 0.64 HTR2A (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0496314-B1 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1997-10-01 — — EP disclosed
US-5472975-A Cognition activators, antidepressants HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-12-05 — — US disclosed
US-5192789-A Antidepressants HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-03-09 — — US disclosed
US-5100891-A Antidepressants HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-03-31 — — US disclosed
Send feedback